R Bassan, T Lerede, G Borleri, B Chiodini, A Rossi, M Buelli, A Rambaldi, P Viero, T Barbui. Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia. haematol [Internet]. 2002Mar.1 [cited 2024Apr.25];87(3):257-63. Available from: https://haematologica.org/article/view/2298